Concepedia

Teresa Gelardi

TG

Statistics

Publications

11

Citations

598

H-Index

11

Active since

2006

Affiliations

University of Naples Federico II(Current)

Idera Pharmaceuticals (United States)

Teresa Gelardi is an author at University of Naples Federico II specializing in oncology, egfr inhibition, and pharmacology.

Publications per year

2006–2013

11

Publications

11

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Roberto Bianco, Roberta Rosa, Vincenzo Damiano et al. · Clinical Cancer Research · 2008 · 146 citations · Full text

, , +17

Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs

Roberto Bianco, Sonia Garofalo, Roberta Rosa et al. · British Journal of Cancer · 2008 · 134 citations · Full text

, , +17

TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts

Vincenzo Damiano, Rosa Caputo, Sonia Garofalo et al. · Proceedings of the National Academy of Sciences · 2007 · 71 citations · Full text

, , +15

Toll-like Receptor 9 Agonist IMO Cooperates with Cetuximab in <i>K</i> - <i>Ras</i> Mutant Colorectal and Pancreatic Cancers

Roberta Rosa, Davide Melisi, Vincenzo Damiano et al. · Clinical Cancer Research · 2011 · 53 citations

, , +17

Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours

Teresa Gelardi, V. Damiano, Roberta Rosa et al. · British Journal of Cancer · 2010 · 39 citations · Full text

, , +16

1–5 of 11